Logo
Research
Portfolio
Services
Log In
Join Now
Search

LIND

RESEARCH


Lind Research provides investor-focused equity research on Nordic companies where we see value. Our coverage is funded by premium subscribers, not issuers, ensuring independence, credibility, and continuity.


LATEST RESEARCH REPORTS & COMMENTS

Date

Report

→

2/3/2026

Market Overreaction Creates Attractive Entry Point

Memo

→

1/30/2026

A New Way to Spot Software Spending Trends Before the Market Does

Note

→

1/8/2026

Physitrack (PTRK): The Thesis Still Holds

Physitrack (PTRK)

Note

→

12/18/2025

Sleep Cycle (SLEEP): Major SDK Licensing Deal Announced

Ticker:SLEEP

@Research Comment

→

12/9/2025

Embracer Group (EMBRACB): 30% Drop Reveals an Attractive Implied Coffee Stain Valuation

Ticker:EMBRACB

Note

→

12/5/2025

Physitrack (PTRK): Extremely Favorable Risk-Reward Situation

Physitrack (PTRK)

Deep Dive

→

11/26/2025

Embracer (EMBRACB): Unleashing the GOAT

Ticker:EMBRACB

Note

→

11/26/2025

Physitrack (PTRK): Strategic Restructuring Aligns With Long-Term Value Creation

Physitrack (PTRK)

Note

→

11/14/2025

Embracer (EMBRACB): Soft Quarter Ahead of CSG Spin-Off

Ticker:EMBRACB

@Research Comment

→

10/24/2025

Physitrack (PTRK): Market Misses the Cash-Flow and SaaS Quality Shift - Earnings comment

Physitrack (PTRK)

@Research Comment

→

Independent | Professional | Unbiased

SUBSCRIBE TO LIND RESEARCH

I consent to receive newsletters via email. Sign up Terms of service.

Lind Research

Portal

© 2026 Lind Capital Holding AB.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv